Literature DB >> 21560065

Depression in Parkinson's disease.

J Schwarz1, P Odin, C Buhmann, I Csoti, W Jost, U Wüllner, A Storch.   

Abstract

Among the recently well appreciated non-motor symptoms in Parkinson's disease (PD), depression plays a prominent role due to its frequency and impact on quality of life. However, depression may be confounded by motor symptoms, especially akinesia and other non-motor symptoms such as apathy, anxiety and dementia. Data on specific diagnostic tools or treatment for depressive symptoms in PD patients are still sparse. Here we summarize an expert opinion based on available data and clinical experience.

Entities:  

Mesh:

Year:  2011        PMID: 21560065     DOI: 10.1007/s00415-011-6048-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Authors:  Paolo Barone; Werner Poewe; Stefan Albrecht; Catherine Debieuvre; Dan Massey; Olivier Rascol; Eduardo Tolosa; Daniel Weintraub
Journal:  Lancet Neurol       Date:  2010-05-07       Impact factor: 44.182

2.  Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.

Authors:  Karl Strecker; Florian Wegner; Swen Hesse; Georg-Alexander Becker; Marianne Patt; Philipp M Meyer; Donald Lobsien; Johannes Schwarz; Osama Sabri
Journal:  J Neurol       Date:  2010-07-21       Impact factor: 4.849

3.  Depression and disability in Parkinson's disease: a follow-up of 132 cases.

Authors:  R G Brown; B MacCarthy; A M Gotham; G J Der; C D Marsden
Journal:  Psychol Med       Date:  1988-02       Impact factor: 7.723

4.  Nonmotor fluctuations in Parkinson's disease: frequent and disabling.

Authors:  Tatiana Witjas; E Kaphan; J P Azulay; O Blin; M Ceccaldi; J Pouget; M Poncet; A Ali Chérif
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

5.  A controlled trial of antidepressants in patients with Parkinson disease and depression.

Authors:  M Menza; R D Dobkin; H Marin; M H Mark; M Gara; S Buyske; K Bienfait; A Dicke
Journal:  Neurology       Date:  2008-12-17       Impact factor: 9.910

6.  A validation study of depressive syndromes in Parkinson's disease.

Authors:  Sergio E Starkstein; Marcelo Merello; Ricardo Jorge; Simone Brockman; David Bruce; Gustavo Petracca; Robert G Robinson
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

7.  Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.

Authors:  Philipp M Meyer; Karl Strecker; Kai Kendziorra; Georg Becker; Swen Hesse; Dominique Woelpl; Anke Hensel; Marianne Patt; Dietlind Sorger; Florian Wegner; Donald Lobsien; Henryk Barthel; Peter Brust; Hermann J Gertz; Osama Sabri; Johannes Schwarz
Journal:  Arch Gen Psychiatry       Date:  2009-08

Review 8.  [Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis].

Authors:  A Storch; G Ebersbach; G Fuchs; W H Jost; P Odin; G Reifschneider; M Bauer
Journal:  Fortschr Neurol Psychiatr       Date:  2008-11-14       Impact factor: 0.752

9.  Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study.

Authors:  David Devos; Kathy Dujardin; Isabelle Poirot; Caroline Moreau; Olivier Cottencin; Pierre Thomas; Alain Destée; Regis Bordet; Luc Defebvre
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

10.  Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.

Authors:  Philippe Remy; Miroslava Doder; Andrew Lees; Nora Turjanski; David Brooks
Journal:  Brain       Date:  2005-02-16       Impact factor: 13.501

View more
  7 in total

Review 1.  Depressive syndromes in neurological disorders.

Authors:  Julian Hellmann-Regen; Dominique Piber; Kim Hinkelmann; Stefan M Gold; Christoph Heesen; Carsten Spitzer; Matthias Endres; Christian Otte
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11       Impact factor: 5.270

2.  The heterogeneity of non-motor symptoms of Parkinson's disease.

Authors:  Ning Zhang; Weiguo Liu; Min Ye; Alexander D Cohen; Yingdong Zhang
Journal:  Neurol Sci       Date:  2014-11-07       Impact factor: 3.307

Review 3.  [Depression and neurological diseases].

Authors:  D Piber; K Hinkelmann; S M Gold; C Heesen; C Spitzer; M Endres; C Otte
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

4.  Effects of sleep disorders on the non-motor symptoms of Parkinson disease.

Authors:  Ariel B Neikrug; Jeanne E Maglione; Lianqi Liu; Loki Natarajan; Julie A Avanzino; Jody Corey-Bloom; Barton W Palmer; Jose S Loredo; Sonia Ancoli-Israel
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

5.  The aqueous extract of Albizia adianthifolia leaves attenuates 6-hydroxydopamine-induced anxiety, depression and oxidative stress in rat amygdala.

Authors:  Galba Jean Beppe; Alain Bertrand Dongmo; Harquin Simplice Foyet; Théophile Dimo; Marius Mihasan; Lucian Hritcu
Journal:  BMC Complement Altern Med       Date:  2015-10-19       Impact factor: 3.659

6.  A Classification System for Assessment and Home Monitoring of Tremor in Patients with Parkinson's Disease.

Authors:  Omid Bazgir; Seyed Amir Hassan Habibi; Lorenzo Palma; Paola Pierleoni; Saba Nafees
Journal:  J Med Signals Sens       Date:  2018 Apr-Jun

7.  Antidepressant-Like Properties of Intrastriatal Botulinum Neurotoxin-A Injection in a Unilateral 6-OHDA Rat Model of Parkinson's Disease.

Authors:  Veronica Antipova; Carsten Holzmann; Alexander Hawlitschka; Martin Witt; Andreas Wree
Journal:  Toxins (Basel)       Date:  2021-07-20       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.